Current Edition

News

Moderna becomes latest company to join the ABPI

The company becomes the latest member of the ABPI and galvanises the company’s UK connections. Moderna is the latest member of the UK’s leading pharmaceutical …

Continue Reading →
News

Sarepta and Catalent expand manufacturing deal ahead of DMD gene therapy approval

Sarepta Therapeutics announced that it has signed a commercial supply agreement with CDMO giant Catalent to manufacture SRP-9001, Sarepta’s most advanced gene therapy candidate for the treatment …

Continue Reading →
News

Artificial pancreas technology set to change lives

Emerging technology could help patients who are unable to manage their type 1 diabetes. Individuals who are typically unable to manage their type 1 diabetes …

Continue Reading →
News

AstraZeneca makes CinCor Pharma acquisition

The agreement involves access to global rights of blood pressure lowering therapy baxdrostat. AstraZeneca (AZ) has agreed to acquire CinCor Pharma (CinCor) – a company …

Continue Reading →
News

Transgene receives approval to begin oncolytic virus trial

The study will evaluate the intravenous administration of the company’s multi-armed immunotherapy. Transgene – a company that develops virus-based immunotherapies for the treatment of cancer …

Continue Reading →
News

BioNTech forms cancer immunotherapies partnership with UK Government

The collaboration will focus on providing up to 10,000 patients with personalised mRNA by 2030. BioNTech has announced a partnership with the UK Government that …

Continue Reading →
News

Tower expands pharmaceutical corridors with new Singapore site

Pharmaceutical thermal protection specialist Tower Cold Chain is opening new office space in Tampines, Singapore, to support the company’s growth in the Asia Pacific region. …

Continue Reading →
News

Novavax begins phase 2 trial for combo influenza-COVID jab

Novavax announced this week that it has initiated the phase 2 trial evaluating the safety and efficacy of the COVID-19-Influenza Combination (CIC) jab in adults aged …

Continue Reading →
News

TG Therapeutics grabs FDA approval for MS drug

TG Therapeutics announced the U.S. FDA has approved its monoclonal antibody for the treatment of relapsing forms of multiple sclerosis (RMS), providing patients with a new treatment …

Continue Reading →
News

FDA says not yet to Ipsen rare bone disease drug

French drugmaker Ipsen announced last week that the FDA had responded to the New Drug application for its fibrodysplasia ossificans progressiva (FOP) therapy, palovarotene, with a Complete …

Continue Reading →